| Literature DB >> 27426105 |
Magdalena Szymusiak1, Xiaoyu Hu2, Paola A Leon Plata1, Paulina Ciupinski1, Zaijie Jim Wang2, Ying Liu3.
Abstract
Curcumin is a bioactive molecule extracted from Turmeric roots that has been recognized to possess a wide variety of important biological activities. Despite its great pharmacological activities, curcumin is highly hydrophobic, which results in poor bioavailability. We have formulated this hydrophobic compound into stable polymeric nanoparticles (nano-curcumin) to enhance its oral absorption. Pharmacokinetic analysis after oral delivery of nano-curcumin in mice demonstrated approximately 20-fold reduction in dose requirement when compared to unformulated curcumin to achieve comparable plasma and central nervous system (CNS) tissue concentrations. This investigation corroborated our previous study of curcumin functionality of attenuating opioid tolerance and dependence, which shows equivalent efficacy of low-dose (20mg/kg) nano-curcumin and high-dose (400mg/kg) pure curcumin in mice. Furthermore, the highly selective and validated liquid chromatography-mass spectrometry (LC-MS) method was developed to quantify curcumin glucuronide, the major metabolite of curcumin. The results suggest that the presence of curcumin in the CNS is essential for prevention and reversal of opioid tolerance and dependence.Entities:
Keywords: Bioavailability; Central nervous system (CNS); Liquid chromatography–mass spectrometry (LC–MS); Nano-curcumin; Oral delivery
Mesh:
Substances:
Year: 2016 PMID: 27426105 DOI: 10.1016/j.ijpharm.2016.07.027
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875